Romain Diamand
@romdiamand
MD, PhD, MCU, FEBU • Hospital Practitioner @JulesBordet • GU Oncology • Robotic Surgery
ID: 712218424672387072
https://www.researchgate.net/profile/Romain_Diamand 22-03-2016 10:04:39
575 Tweet
412 Followers
584 Following
⁉️ Transrectal or transperineal biopsy #ProstateCancer ? Prostate Cancer and Prostatic Diseases Simone Albisinni Peltier Alexandre Institut Jules Bordet Instituut 🔗 nature.com/articles/s4139… ⚔️ nature.com/articles/s4139…
🤔 To preserve or not to preserve the NVB in high-risk #ProstateCancer during #RALP Simone Albisinni Peltier Alexandre Thierry Roumeguere Gaelle Fiard Ploussard Guillaume Institut Jules Bordet Instituut link.springer.com/article/10.100…
Follow us Live for the #Nextgen event! See young proficient surgeons giving their best! Orsi Academy Stefano Puliatti MD Paolo Dell'Oglio Ruben De Groote Alex Mottrie Romain Diamand Sophie Knipper Daniele Amparore surgquest.com/event/wrse-uro…
Final results of PREVENT Jim Hu Andrew Vickers Edward Schaeffer, MD, PhD shows significant decrease in infection for TP vs TR biopsy (p=0.015). I think we were pretty well powered 😉
🚀 I'm thrilled to announce the publication of the FOSTINE study in BJU International evaluating the outcomes of Targeted Microwave Ablation using KOELIS, a new energy modality for focal therapy in prostate cancer Institut Jules Bordet Instituut Peltier Alexandre bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
📏 Impact of ellipsoidal formula vs semi-automated segmentation using 3D-US on PSAd estimations and distribution of patients in a risk-adapted table of csPCa @WJUrol Arthur Baudewyns Institut Jules Bordet Instituut links.springernature.com/f/a/ariuW2QqFa…
Delighted to see this in print! Urinary and sexual outcomes after radical prostatectomy in 26 UK centres, reporting urine leakage, pad use and erections with & without medication European Urology Open Science Muhieddine Labban Alexander P Cole Quoc-Dien Trinh, MD, MBA Kev Hamer eur01.safelinks.protection.outlook.com/?url=https%3A%…
Targeted microwave ablation for #ProstateCancer. This “ablate-&-resect” study demonstrated complete necrosis within ablation zone on surgical specimens, plus feasibility & safety. Peltier Alexandre Roland van Velthoven Arthur Baudewyns Grégoire Assenmacher Romain Diamand doi.org/10.1111/bju.16…
🚀 Excited to share our latest European study on the external validation and comparison of MRI-based models predicting the risk of csPCa @WJUrol Institut Jules Bordet Instituut Monique Roobol Hein Van Poppel KOELIS 🥇 MRI-#ERSPC model published by Alberts et al. link.springer.com/article/10.100…
🙌 Glad to share our new study on risk stratification for PI-RADS 3 lesions using PSAd in Prostate Cancer and Prostatic Diseases 𝗚𝗲𝗼𝗿𝗴𝗲𝘀 𝗠𝗷𝗮𝗲𝘀𝘀 💬 Key findings: the use of a PSAd cut-off of 0.13 can reduce unnecessary biopsy Institut Jules Bordet Instituut nature.com/articles/s4139…
📰 Exciting News in Prostate Cancer Research! 📰 Our latest study shows that for patients with PI-RADS 3 lesions and a PSA density below 0.13 ng/ml/cc, especially below 0.09, prostate biopsy can be omitted! 🚫🔬📉 𝗚𝗲𝗼𝗿𝗴𝗲𝘀 𝗠𝗷𝗮𝗲𝘀𝘀 Romain Diamand
🇪🇺 Great collaboration again with our European friends and colleagues Institut Jules Bordet Instituut KOELIS Peltier Alexandre Thierry Roumeguere Ploussard Guillaume Marco Oderda Paolo Gontero Gaelle Fiard Karsten Guenzel Julien Anract Charles Dariane Grégoire Assenmacher
Sharing our Words of Wisdom about factors impacting #treatment decision making +#DecisionRegret in patients with #ProstateCancer ➡️Patients wish to actively participate and we should regard this as a mandate Maarten Albersen #MatthiasMay European Urology 👉sciencedirect.com/science/articl…